Mabwell (Shanghai) Bioscience Co., Ltd. has been added to Shanghai Stock Exchange Composite Index.
Mabwell (Shanghai) Bioscience Co., Ltd.
Equities
688062
CNE100005RD2
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.98 CNY | +2.80% | +6.66% | -11.35% |
07-16 | FDA Grants Orphan Drug Designation to 7MW3711 | CI |
07-15 | Mabwell Receives NMPA Approval for Clinical Trial of Novel Nectin-4 Targeting ADC in TNBC | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.35% | 1.59B | |
+20.03% | 126B | |
+23.61% | 117B | |
+22.88% | 27.52B | |
-18.07% | 20.87B | |
-13.85% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- 688062 Stock
- News Mabwell (Shanghai) Bioscience Co., Ltd.
- Mabwell Bioscience Co., Ltd.(SHSE: 688062) added to Shanghai Stock Exchange Composite Index